In this issue:
- Late-breaking studies from the American College of Cardiology (ACC) 2024 scientific sessions (6–8 April, Atlanta, USA) including the SMART trial, ORBITA-COSMIC, RELIEVE-HF and more.
- Coverage of the Cardiovascular Research Technologies (CRT) 2024 meeting (9–12 March, Washington, DC, USA) including new research on radiation reduction technologies and the use of drug-coated balloons in percutaneous coronary intervention (PCI).
- In profile: Nicolas Dumonteil
- Updates from the 2024 Charing Cross (CX) Symposium (23–25 April, London, UK) including analysis of the impact of restrictions on the use of paclitaxel-coated devices, and analysis from the LIFE-BTK trial.
